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Available online 18 November 2015AbstractBackground: The common garden plant autumn crocus contains colchicine and its derivatives. Colchicine poisoning causes abdominal cramps
and diarrhea within hours. Several days later, multiorgan failure, pancytopenia, and cardiovascular collapse occur.1,2 Severe colchicine poisoning
is associated with high mortality.
Case report: A 63-year-old woman who accidentally ingested an autumn crocus, which contained ~0.38 mg colchicine, had severe vomiting and
was taken to an emergency center. She presented with symptoms of gastroenterocolitis within 1 hour of ingestion, and bone marrow hypoplasia
with pancytopenia developed on the 3rd day after ingestion. We continued administration of granulocyte colony-stimulating factor (300 mg) for 5
days until we confirmed that the patient's white blood cell count was increasing. Also, there was focal and segmental intestinal ischemia and
some cakes of charcoal remained in the intestinal tract. Therefore, we presumed that nonocclusive mesenteric ischemia was caused by hypo-
tension with severe dehydration, although pseudo-obstruction due to the activated charcoal may have been a contributing factor. We were able to
promptly intervene to treat paralytic ileus and gastrointestinal edema before anticipated worsening of abdominal compartment syndrome, by
conducting open peritoneal drainage. Despite severe poisoning, our patient survived with intensive care. Conclusion: Colchicine intoxication
may lead to a sudden and extreme critical course. Therefore, as there is no means to predict prognosis from initial severity of symptoms at onset,
we suggest that all patients suspected of colchicine intoxication should be managed in hospital with continuous vital sign monitoring and
frequent laboratory testing for at least a few days after ingestion.
Copyright © 2015, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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The common garden plant autumn crocus (Colchicum
autumnale) contains numerous biologically active substances
including colchicine and its derivatives.1,2 As the leaves and
roots of the autumn crocus closely resemble a Japanese herb,
people occasionally eat it inadvertently.* Corresponding author. Advanced Critical Care and Emergency Center,
Department of Emergency Medicine, Sapporo Medical University, S1, W16,
Chuo-ku, Sapporo, Hokkaido, Japan.
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2211-5587/Copyright © 2015, Taiwan Society of Emergency Medicine. PublishedColchicine poisoning causes abdominal cramps and diar-
rhea within hours. Several days later, multiorgan failure,
pancytopenia, and cardiovascular collapse occur.1,2 Severe
colchicine poisoning is associated with high mortality. We
report a case of severe accidental colchicine poisoning suc-
cessfully treated with intensive management.2. Case Report
A previously healthy 63-year-old woman accidentally
ingested an autumn crocus after she had misidentified it asby Elsevier Taiwan LLC. All rights reserved.
Table 2
Colchicine concentration in the serum.
(d) 2 3 4 5 6 7 8 9 10 11
Colchicine (ng/mL) 2.3 1.6 1.2 1.2 1.3 1 0.5 0.41 0.19 N.D.
Colchicine concentration in serum was measured by the Poisoning and Drug
Laboratory Division.
The maximum concentration of colchicine in the blood was 2.3 ng/mL on Day
2. Despite this blood concentration being less than the toxic concentration
identified by Molad,3 the patient's course was severe. N.D. ¼ Not Detected.
Figure 1. Abdominal X-ray showing paralytic ileus on Day 6.
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episodes of severe vomiting and was taken to an emergency
center with the remaining plant that she had not eaten. It was
estimated that she ingested about 11 mg of the autumn crocus,
which contained ~0.38 mg of colchicine. The colchicine
concentration of the root of the C. autumnale was measured by
high-performance liquid chromatography at Hokkaido Insti-
tute of Public Health. On the day after ingestion, she was
transported to our tertiary care center due to hypotension and
laboratory evidence of acute liver failure.
Early on the second day, her vital signs were respiratory
rate 26 breaths/min, pulse 102 beats/min, blood pressure 97/
76 mm Hg, tympanic temperature 36.3C, and Glasgow Coma
Scale 15. Her abdomen was soft but diffusely tender. On
echocardiography, the left ventricle wall motion demonstrated
diffuse hypokinesis with a left ventricular ejection fraction of
25e30%. Due to her worsening clinical condition, she was
electively intubated and placed on mechanical ventilation. She
was treated with aggressive fluid resuscitation and adminis-
tration of norepinephrine, with repeated dose of activated
charcoal (AC). Laboratory test results are shown in Table 1.
Colchicine concentration in serum was measured by the
Poisoning and Drug Laboratory Division (Table 2).
On Day 5, the laboratory test revealed leukopenia and
thrombocytopenia. Cefepime hydrochloride and vancomycin
were administered for prevention of infection, and 300 mg
granulocyte colony-stimulating factor (G-CSF) was adminis-
tered each day during the subsequent 5 days. An abdominal
radiograph was obtained on Day 6, which was consistent with
paralytic ileus (Figure 1) and gastrointestinal edema, and the
patient developed septic shock, for which we performed an
emergency laparotomy (Figure 2) and open abdominal man-
agement. Intraoperatively, therewas no bowel necrosis, but focal
and segmental ischemia of the jejunum, without occlusion of the
mesenteric artery and vein. There were some cakes of charcoal.
We therefore made a diagnosis of nonocclusive mesenteric
ischemia (NOMI). Observation of NOMI can be followed by
second-look operation. It was presumed that NOMIwas induced
by the paralytic ileus from colchicine intoxication, with resultant
circulatory insufficiency due to septic shock. After laparotomy,
we used polymyxin-B-based cartridges (Toraymyxin) to remove
endotoxins for 3 hours.4,5 Subsequently, we introduced contin-
uous hemodiafiltration for renal indication to treatment of re-
fractory fluid overload.Table 1
Laboratory findings after Colchicum autumnale intoxication.
Unit Normal range Measured value
(d) 1 2 3 4
AST IU/L 11e39 46 374 754 436
ALT IU/L 5e40 24 176 354 233
CRP mg/dL 0.0e0.3 0.08 7.45 10.84 7.97
CRE mg/dL 0.45e0.94 0.77 0.83 1.1 0.8
UN mg/dL 6.0e20.0 14.6 18.8 25 24
Laboratory test revealed leukopenia and thrombocytopenia on Day 5 and the pati
ALT ¼ alanine aminotransferase; AST ¼ aspartate aminotransferase; CRE ¼ creaOn Day 9, her myelosuppression improved (Figure 3). She
made a full recovery from septic shock and was successfully
weaned from mechanical ventilation on Day 13. She required
continuous hemodiafiltration and was switched to intermittent
hemodiafiltration on Day 18, and then subsequently weaned
from renal replacement therapy completely on Day 23. On
Day 34, the patient was transferred to a rehabilitation facility
with biochemical and hematological laboratory values within
normal ranges.5 6 7 8 9 10 33
223 86 47 21 24 30 16
177 104 80 48 32 36 23
15.16 22.35 41.85 42.67 33.7 20.38 0.34
0.5 0.4 0.8 0.8 1.1 1.4 0.8
15 11 24 30 39 51 3.6
ent developed septic shock on Day 6. Myelosuppression improved on Day 9.
tinine; CRP ¼ C-reactive protein; UN ¼ urea nitrogen.
Figure 2. Intraoperative findings. There was no bowel necrosis, but focal and
segmental ischemia of the jejunum, without occlusion of the mesenteric artery
and vein.
Figure 3. White blood cell (WBC) and platelet response to G-CSF administration. We administered 75 mg G-CSF once (Day 5), however, 300 mg G-CSF was
administered once daily during the subsequent 3 days because WBC count decreased rapidly. After 5 days (Day 9), WBC count began to increase. Platelet count
had not increased on Day 10. G-CSF ¼ granulocyte colony-stimulating factor; Plt ¼ platlet.
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Colchicine binds to tubulin, thereby preventing its poly-
merization into microtubules. Microtubule deficiency leads to
impairment of many cellular functions.6 Tissues with high
mitotic activity are preferentially affected. As an antimitotic
agent, colchicine blocks mitosis in metaphase, preventing
DNA synthesis.
In toxic doses of colchicine, the toxin binds to specific
regions on tubulin and can interfere with microtubule structure
and function.6 These effects occur in all cells, which explain
the multiorgan toxicity seen with poisoning.7 Organ systems
with the highest cell turnover rate (bone marrow, gastrointes-
tinal tract, and hair follicles) are the most vulnerable and
readily affected.
The clinical course of acute colchicine poisoning generally
occurs in three phases.6 The first phase is characterized by
vomiting and diarrhea, which generally start 4e12 hours after
ingestion. The second phase begins 2 or 3 days after poisoningand is characterized by life-threatening complications such as
circulatory failure, arrhythmias, renal failure, hepatic failure,
respiratory distress, bone marrow depression, and coagulop-
athy. Complications such as gastrointestinal hemorrhage and
disseminated intravascular coagulation frequently occur. The
third phase of colchicine poisoning occurs 7e21 days after
ingestion, which is characterized by rebound leukocytosis,
alopecia, and possibly other complications including delirium,
stupor and coma, and seizures.6 Our patient presented with
symptoms of gastroenterocolitis within 1 hour of ingestion,
and bone marrow hypoplasia with pancytopenia developed on
the third day after ingestion.
Despite severe poisoning, our patient survived with inten-
sive care. To investigate the relationship between poisoning
symptoms and severity, a literature search was conducted by
searching the PubMed database between 1993 and January
2013 using keywords “colchicine” and “poisoning”. This
search identified 186 papers. This list was manually screened
for papers relating to colchicine poisoning in humans, themechanism of toxicity, or its clinical management. This yiel-
ded a total of 78 papers. Seventeen of the papers were related
to accidental plant ingestion. There was considerable variation
among all factors in the poisoning, including time to symptom
onset, age, amount ingested, and method of poisoning. How-
ever, we did not find any association between poisoning
severity and these factors.7e21 In colchicine poisoning, there is
no clear correlation between the amount of plant matter
ingested and serum concentrations.6,22 Usually, toxic effects
do not occur with concentrations <3 ng/mL.21 Moreover, the
concentration of colchicine in blood and bile is poorly corre-
lated.8,22 In our case, the maximum concentration of colchi-
cine in blood was 2.3 ng/mL. Despite this blood concentration
being less than the toxic concentration identified by Molad,3
the patient's course was severe. Due to its unpredictable
outcome, Brncic et al9 recommend that all patients suspected
of colchicine intoxication should be managed with intensive
care monitoring and support, irrespective of the actual degree
of poisoning.
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should be given every 6 hours to reduce intestinal absorption
of colchicine. Putterman et al stated that multiple-dose acti-
vated charcoal (MDAC) therapy should be considered because
of enterohepatic recirculation during colchicine poisoning.23
However, the adverse effects include intestinal obstruction
and pseudo-obstruction after repeated doses of AC in the
presence of dehydration. In colchicine poisoning, gastroin-
testinal irritant effects such as vomiting and diarrhea occur and
may lead to severe hypovolemic shock. Severe hypovolemic
shock may cause NOMI. In our case, there was also focal and
segmental intestinal ischemia and some cakes of charcoal
remained in the intestinal tract. Therefore, we presume that
NOMI was caused by severe hypovolemic shock, although
pseudo-obstruction due to the AC may have been a contrib-
uting factor. These factors point to a need for careful moni-
toring of warning signs of intestinal ischemia during
management with MDAC therapy. We were able to promptly
intervene to treat paralytic ileus and gastrointestinal edema
before the anticipated worsening of abdominal compartment
syndrome, by surgical abdominal decompression.
In this case, granulocytopenia was improved by the
administration of G-CSF. We continued administration of G-
CSF (300 mg) for 5 days until we confirmed the patient’s white
blood cell count was increasing. G-CSF can be an effective
supportive care measure for granulocytopenia induced by
colchicine intoxication, as it is thought to help prevent septi-
cemia. Finkelstein et al7 reported that G-CSF should be
considered if there is myelosuppression. Critchley et al suc-
cessfully treated a patient with severe colchicine poisoning
using 600 mg G-CSF. When G-CSF is used, daily monitoring
of the patient's hematological status is strongly
recommended.24
In conclusion, colchicine intoxication may lead to a sudden
and extreme critical course. Therefore, as there is currently no
means to predict prognosis from initial severity of symptoms
at onset, we suggest that all patients suspected of colchicine
intoxication should be managed in hospital with continuous
vital sign monitoring and frequent laboratory testing for at
least a few days after ingestion. Caution must be exercised
with the use of MDAC, as it may cause or accelerate intestinal
ischemia. Lastly, G-CSF can be an effective therapy in the face
of myelosuppression after colchicine poisoning.
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